| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00284921 Details | 2011-11-02 Interventional | 3 | - | Mycophenolic Ac… Hepatitis Hepatitis C De Novo Kidney … | - - | |||
| NCT01049204 2008-006769-95 Details | 2011-11-01 Interventional | 4 | 48 | Maraviroc HIV Infections | The data from the first 48 patients recruited has now been analysed, and it has been determined
that it is sufficient to meet the study objectives. - | |||
| NCT01458548 Details | 2011-10-25 Interventional | 2 | 70 | Rituximab Lymphoprolifera… Post-transplant… | This study had an major amendment in 12/2006 introducing risk stratified sequential treatment
(RSST). The modified protocol is registered with NCT00590447. - | |||
| NCT00461890 Details | 2011-10-24 Interventional | 4 | - | Naltrexone Alcoholism Substance-Relat… Alcohol Depende… Veterans | - - | |||
| NCT00051584 NCT00056017 Details | 2011-10-24 Interventional | 2 | - | Doxorubicin Gemcitabine Immunoconjugate… Ovarian Neoplas… | - - | |||
| NCT00028483 Details | 2011-10-24 Interventional | 2 | - | Docetaxel Doxorubicin Immunoconjugate… Breast Neoplasm… Breast Cancer | - - | |||
| NCT01260844 Details | 2011-10-21 Interventional | 1 | - | Antibodies, Mon… Psoriasis Moderate to Sev… | Study stopped - | |||
| NCT00865878 Details | 2011-10-21 Interventional | 2 | 6 | Aminolevulinic … Keratosis Keratosis, Acti… Skin Neoplasms Actinic Keratos… | Orphan Drug Designation for this indication not granted - | |||
| NCT01454440 2007-002617-39 Details | 2011-10-19 Interventional | 4 | 91 | Eptifibatide Coronary Artery… Coronary Diseas… Myocardial Isch… | The study was stopped prematurely due to slow enrolment without code breaking. - | |||
| NCT00953472 Details | 2011-10-12 Interventional | 1 | - | Natriuretic Pep… Hypertension Hypertension St… | - - | |||
| NCT00841633 Details | 2011-10-12 Interventional | 3 | 15 | Norepinephrine Brain Ischemia Cerebral Infarc… Hemorrhage Hypertension Ischemia Subarachnoid He… Cerebral Ischem… | Our RCT recently started. The RCT is similar to the feasibility trial, so it was terminated to
avoid 2 trials running simultaniously. - | |||
| NCT00125346 Details | 2011-10-12 Interventional | 3 | 98 | Tobramycin Cystic Fibrosis Fibrosis Respiratory Asp… | per Data Monitoring Committee recommendation - | |||
| NCT00723411 Details | 2011-10-10 Interventional | 3 | 334 | Aluminum sulfat… Diabetes Mellit… Diabetes Mellit… Type 1 Diabetes… | The primary endpoint at 15 months was not met. - | |||
| NCT01447563 Details | 2011-10-06 Interventional | 1 | 32 | Clopidogrel Comparative Bio… | - - | |||
| NCT00381654 Details | 2011-10-04 Interventional | 1 | 27 | MP 412 Neoplasms Tumor | Study did not meet pre-specified objectives. - | |||
| NCT00516685 Details | 2011-09-30 Interventional | 2/3 | - | Monatide (IMS 3… Carcinoma, Non-… Lung Neoplasms Non-small-cell … | Due to inability of patient enrollment, decision taken to terminate in the interests of
patients and later Malaysia is incorporated into global Phase 3 trial. - | |||
| NCT00941135 2008-003365-29 Details | 2011-09-29 Interventional | 2 | - | Cetuximab Docetaxel Laryngeal Neopl… | - - | |||
| NCT01002183 Details | 2011-09-27 Interventional | 2 | - | Fosmidomycin Malaria | Drug combination is no longer pursued - | |||
| NCT00787917 Details | 2011-09-26 Interventional | 4 | 14 | Itraconazole Omalizumab Aspergillosis Aspergillosis, … Cystic Fibrosis Fibrosis Pulmonary Asper… Allergic Bronch… | - - | |||
| NCT01089790 Details | 2011-09-21 Interventional | 3 | 141 | Sitagliptin Pho… Diabetes Mellit… Diabetes Mellit… | - - |